Project Grant R43HD117450
Award Date
5/1/25
Completion Date
4/30/26
Dollars Obligated
$385K
Funding Federal Agency
National Institute of Neurological Disorders and Stroke
Awarding Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $299,518 Project Grant under the Drug Abuse and Addiction Research Programs (CFDA 93.279) to V-Flow Medical Inc. to develop a novel diagnostic catheter and modular stent system to treat pelvic venous insufficiency (PVI), a primary cause of chronic pelvic pain (CPP) in women. The project will utilize an ovine model to evaluate the safety and efficacy of V-Flow's catheter and stent system in improving clinical outcomes...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $384,973 to Bold Type LLC, a minority-owned small disadvantaged business, to develop an intravaginal, wearable medical device called "Violet". The device is designed to provide on-demand electrical nerve stimulation and vibration therapy to treat high tone pelvic floor dysfunction,...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), will validate a novel near-infrared spectroscopy (NIRS) optical imaging technology to quantify pelvic floor muscle fitness in patients with myofascial pelvic pain (MPP). The $1,516,765 award to the University of California, Los Angeles (UCLA) aims to establish NIRS as an effective, non-invasive method to assess pelvic floor muscle...
This $384,558 Project Grant award from the National Institutes of Health's (NIH) Child Health and Human Development Extramural Research program (CFDA 93.865) supports the development and evaluation of the "SenseWand" - a wireless pelvic floor diagnostic system (device and app) to assess pelvic floor muscle health using Electrical Impedance Myography (EIM). The recipient, Bold Type LLC, is a minority-owned, small disadvantaged business developing innovative medical devices and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $6,154,752 to fund a 3-year clinical study on how menstrual pain (dysmenorrhea) and bladder hypersensitivity influence the development of chronic pelvic pain (CPP) conditions. The research, conducted by Northshore University Healthsystem Research Institute, aims to identify sensory mechanisms and biomarkers that predict...
The federal Project Grant award, issued by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865), supports the development of the SOLESTIM Neuromodulation System, a portable, non-invasive device for treating dysmenorrhea (menstrual cramps). The $343,510 grant will fund a 16-week pilot clinical study to evaluate the feasibility and acceptability of the SOLESTIM system as a home-use treatment for...
The National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, awarded Backstop Neural, Inc. a $970,052 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a novel softening epidural stimulation lead for treating chronic arm and neck pain. The project aims to design and fabricate a thin, flexible 16-channel epidural lead that can conform to the spinal cord and provide stable, long-term stimulation. Key...
This $474,946 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research program) supports the development of a novel, female-initiated, non-hormonal contraceptive device. The key products and services being delivered under this grant include: The design and fabrication of a dual-compartment vaginal device that enables women to self-administer a polymeric "smart" fiber mat and a...
The National Institute of Child Health and Human Development (NICHD) awarded Madorra Inc. a $1,514,498 SBIR Direct-to-Phase II Project Grant (CFDA 93.865) to develop and clinically evaluate a novel, non-hormonal, ultrasound-based medical device for the treatment of vulvovaginal atrophy (VVA). This condition, which affects up to 90% of peri- and post-menopausal women as well as many breast cancer survivors, leads to pain, reduced libido, and decreased quality of life. The project aims to 1)...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is focused on enhancing pain management for knee replacement patients through an innovative non-invasive and opioid-sparing device. The $416,443 award to NCAP Medical, LLC will fund a randomized placebo-controlled clinical trial to evaluate the use of the "Neurocuple" device as a non-pharmacological postoperative pain relief treatment following...